Response to letter to the editor from Viola et al: "calcifediol treatment and COVID-19-related outcomes"

Nogués Solan, Francesc XavierQuesada-Gómez, J.M.García-Giralt, Natalia2022-09-072021Nogués X, Quesada-Gomez JM, Garcia-Giralt N. Response to letter to the editor from Viola et al: "calcifediol treatment and COVID-19-related outcomes". J Clin Endocrinol Metab. 2021 Nov 19; 106(12): e5281-2. DOI: 10.1210/clinem/dgab566.0021-972Xhttp://hdl.handle.net/10230/54012application/pdfeng© Oxford University Press. This is a pre-copyedited, author-produced version of an article accepted for publication in The Journal of clinical endocrinology and metabolism following peer review. The version of record Nogues X, Quesada-Gomez JM, Garcia-Giralt N. Response to letter to the editor from Viola et al: "calcifediol treatment and COVID-19-related outcomes". J Clin Endocrinol Metab. 2021 Nov 19; 106(12): e5281-2, is available online at: https://academic.oup.com/jcem/article/106/12/e5281/6333153?login=true.COVID-19 (Malaltia) -- TractamentResponse to letter to the editor from Viola et al: "calcifediol treatment and COVID-19-related outcomes"info:eu-repo/semantics/articlehttp://dx.doi.org/10.1210/clinem/dgab566info:eu-repo/semantics/openAccess